Australia - English - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - pyridoxal 5-phosphate monohydrate, quantity: 62.7 mg (equivalent: pyridoxine, qty 40 mg); riboflavin sodium phosphate, quantity: 10 mg (equivalent: riboflavin, qty 7.3 mg); choline bitartrate, quantity: 300 mg (equivalent: choline, qty 123.39 mg); levomefolate calcium, quantity: 433.13 microgram (equivalent: levomefolic acid, qty 400 microgram); camellia sinensis, quantity: 160 mg (equivalent: camellia sinensis, qty 4 g; equivalent: caffeine, qty 12 mg; equivalent: polyphenols calculated as gallic acid (of - tablet, film coated - excipient ingredients: iron oxide red; macrogol 8000; hypromellose; colloidal anhydrous silica; microcrystalline cellulose; sodium starch glycollate; silicon dioxide; carnauba wax; magnesium stearate - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; helps convert (state food) into energy ; maintain/support energy production ; maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range ; aid/assist/helps synthesis of neurotransmitters

United States - English - NLM (National Library of Medicine)

virtus pharmaceuticals llc - levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w) - levomefolate calcium 3 mg - hyperhomocysteinemia of any etiology. medical foods are intended for the patient who has a limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by the modification of the normal diet alone1 . l-methyl-b6-b12 is a specially formulated medical food for the dietary support of patients with hyperhomocysteinemia. it also is helpful in managing patients with high total homocysteine concentrations associated with malabsorption of vitamin b12 or suboptimal intake of b vitamins. l-methyl-b6-b12 tablets should always be used under medical supervision. l-methyl-b6∙b12 is contraindicated in patients with known hypersensitivity to any of the components contained in this product. discontinue use if patient exhibits signs of hypersensitivity such as tachycardia, urticaria, or shortness of breath.

United States - English - NLM (National Library of Medicine)

foxland pharmaceuticals, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1 - trinaz tablets are contraindicated in patients with a known hypersensitivity to any of the ingredients. do not take this product if you are presently taking mineral oil, unless directed by a doctor.

Australia - English - Department of Health (Therapeutic Goods Administration)

metagenics (aust) pty ltd - pyridoxal 5-phosphate monohydrate, quantity: 5.26 mg/g (equivalent: pyridoxine, qty 3.36 mg/g); calcium ascorbate dihydrate, quantity: 318.52 mg/g (equivalent: ascorbic acid, qty 263.16 mg/g); zinc amino acid chelate, quantity: 65.78 mg/g (equivalent: zinc, qty 13.15 mg/g); betacarotene, quantity: 1.052 mg/g; colecalciferol, quantity: 0.0065 mg/g - powder, oral - excipient ingredients: hypromellose; citric acid; steviol glycosides; potassium citrate; colloidal anhydrous silica; beta vulgaris; maltodextrin; tartaric acid; starch sodium octenyl succinate; maize starch; sodium ascorbate; dl-alpha-tocopherol; liquid glucose; flavour; acacia; silicon dioxide; sucrose; medium chain triglycerides - maintain/support immune system health ; maintain/support healthy immune system function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support reproductive system health ; decrease/reduce/relieve common cold duration ; soothe/relieve skin inflammation ; maintain/support wound healing ; maintain/support skin repair/healing/regeneration

Australia - English - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals pty ltd - pyridoxal 5-phosphate monohydrate, quantity: 51.09 mg (equivalent: pyridoxine, qty 32.6 mg); riboflavin sodium phosphate, quantity: 32.89 mg (equivalent: riboflavin, qty 25 mg); mecobalamin, quantity: 1 mg; serine, quantity: 50 mg; choline bitartrate, quantity: 300 mg; levomefolate calcium, quantity: 542 microgram (equivalent: levomefolic acid, qty 500 microgram) - tablet, film coated - excipient ingredients: potable water; microcrystalline cellulose; povidone; purified water; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; silicon dioxide; magnesium stearate; carnauba wax; hypromellose; macrogol 400; crospovidone - maintain/support energy levels ; maintain/support energy production ; aid/assist healthy red blood cell production ; helps maintain/support haemoglobin formation/synthesis ; helps decrease/reduce homocysteine levels ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system function ; maintains/support healthy foetal development

United States - English - NLM (National Library of Medicine)

basiem - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), nadh (unii: 4j24dq0916) (nadh - unii:4j24dq0916), coenz - ascorbic acid 125 mg - xyzbac tablets is an orally administered prescription vitamin formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced folate supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.

United States - English - NLM (National Library of Medicine)

tmig inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), nadh (unii: 4j24dq0916) (nadh - unii:4j24dq0916), coenz - ascorbic acid 125 mg - zyvit tablets is an orally administered prescription vitamin formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced folate supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - clinical chemistry - in vitro test for the quantitative determination of aspartate aminotransferase (ast) with pyridoxal phosphate activation in human serum and plasma on roche/hitachi cobas c systems.

United States - English - NLM (National Library of Medicine)

innovida phamaceutique corporation - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), pyridoxal 5-phosphate glutamate (unii: up2u9o910m) (pyridoxal - unii:3thm379k8a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cobalamin (unii: 8406ey2oqa) (cobalamin - unii:8406ey2oqa), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), ferrous bisglycinate (unii -

United States - English - NLM (National Library of Medicine)

carwin pharmaceutical associatates, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), levomefolate glucosamine (unii: q65pl71q1a) (levomefolate glucosamine - unii:q65pl71q1a), folic acid (unii: 935e97boy8) (folic - natal pnv tablets are contraindicated in patients with a known hypersensitivity to any of the ingredients. do not take this product if you are presently taking mineral oil, unless directed by a doctor.